Pediatric Henoch-Schönlein purpura

International Journal of Dermatology

Volumn 48, Issue 11, 2009, Pages 1157-1165

  González, Lenis M ^a   Janniger, Camila Krysicka ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; CYCLOSPORIN A; CYTOKINE; DAPSONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID; HLA DR ANTIGEN; HYDROCORTISONE; IMMUNOGLOBULIN A; INTERCELLULAR ADHESION MOLECULE 1; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL PAIN; ANAMNESIS; ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTHRITIS; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL SYMPTOM; GENERALIZED EDEMA; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; LOW DRUG DOSE; MACULOPAPULAR RASH; MOON FACE; NONTHROMBOCYTOPENIC PURPURA; PEDIATRICS; PHYSICAL EXAMINATION; REVIEW; SIDE EFFECT; SKIN BIOPSY; WEIGHT GAIN;

CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; PURPURA, SCHOENLEIN-HENOCH; SKIN;

EID: 70449379279     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04162.x     Document Type: Review

References (88)

1. Praid D, Amir J, Nussinovitch M. Recurrent Henoch-Schonlein purpura in children. J Clin Rheumatol 2007, 13:25-28.
2. Pabunruang W, Treepongkaruna S, Tangnararatchakit K. Henoch-Schonlein purpura: clinical manifestations and long-term outcomes in Thai children. J Med Assoc Thai 2002, 85(Suppl. 4):S1213-S1218.
3. Saulsbury FT. Henoch-Schönlein purpura. Curr Opin Rheumatol 2001, 13:35-40.
4. Ozen S. The spectrum of vasculitis in children. Best Prac Res Clin Rheumatol 2002, 16:411-425.
5. Saulsbury FT. Henoch-Schönlein purpura in children: report of 100 patients and review of the literature. Medicine 1999, 78:395-409.
6. Calvino MC, Llorca J, Garcia-Porrua C. Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001, 80:279-290.
7. Garcia-Porrúa C, Calvino MC, Llorca J. Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002, 32:149-156.
8. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V. Henoch-Schönlein purpura in adulthood and childhood. Two different expressions of the same syndrome. Arthritis Rheum 1997, 40:859-864.
9. Rostoker G. Schönlein-Henoch purpura in children and adults. Biodrugs 2001, 15:99-138.
10. Fervenza FC. Henoch-Schönlein purpura nephritis. Int J Dermatol 2003, 42:170-177.
11. Heberden W. Reprinted as. Commentaries on the History and Cure of Diseases 1982, 395-397. London, Payne, Birmingham, AL, The Classics of Medicine Library, Division of Gryphon Editions, Ltd
12. Schönlein JL. Allgemeine und Specielle Pathologie und Therapie 1837, 48. Vol. 2, 3rd edn, Wurzburg, Herisau
13. Henoch EH. Über eine eigenthumliche Form von Purpura. Berl Klin Wochenschr 1874, 11:641-643.
14. Henoch EH, Hirschward A. Vorlesungen uber Kinderkrankheiten. Vohlesunger uber Kinderkrankheiten 1899, 839. In, ed, Berlin, Aufl
15. Osler W. Visceral lesions of purpura and allied conditions. Br Med J 1914, 1:517.
16. Frank E. Die essentielle Thrombopenie. Berl Klin Wochenschr 1915, 52:454-458.
17. Gairdner D. The Schönlein-Henoch syndrome (anaphylactoid purpura). Q J Med 1948, 17:95-122.
18. Islek I, Kalayci AG, Gok F. Henoch-Schönlein purpura associated with hepatitis A infection. Pediatr Int 2003, 45:114-116.
19. Amoli MM, Thomson W, Hajeer AH. HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. J Rheumatol 2001, 28:1266-1270.
20. Amoroso A, Berrino M, Canale L. Immunogenetics of Henoch-Schönlein disease. Eur J Immunogenet 1997, 24:323-333.
21. Amoli MM, Thomson W, Hajeer AH. HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol 2002, 29:948-949.
22. Farley TA, Gillespie S, Rasoulpour M. Epidemiology of a cluster of Henoch-Schönlein purpura. Am J Dis Child 1989, 143:798-803.
23. Levy-Khademi F, Korman SH, Amitai Y. Henoch-Schönlein purpura: simultaneous occurrence in two siblings. Pediatr Dermatol 2000, 17:139-140.
24. Ilan Y, Naparstek Y. Henoch-Schönlein purpura in children and adults: is it one entity?. Semin Arthritis Rheum 2002, 32:139-140.
25. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schönlein-Henoch syndrome). Am J Dis Childhood 1960, 99:833-854.
26. Al-Sheyyab M, El-Shanti H, Ajlouni S. Henoch-Schönlein purpura: clinical experience and contemplations on a streptococcal association. J Trop Pediatr 1996, 42:200-203.
27. Pillebout E, Thervet E, Hill G. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002, 13:1271-1278.
28. Cioc AM, Sedmak DD, Nuovo GJ. Parvovirus B19 associated adult Henoch-Schönlein purpura. J Cutan Pathol 2002, 29:602-607.
29. Frankum B, Katelaris CH. Hepatitis C infection and Henoch-Schönlein purpura. Aust NZ J Med 1995, 25:176.
30. Gharvari AE, Patel BM, Hughes GR. Common IgA and IgM rheumatoid factor idiotypes in autoimmune disease. Ann Rheum Dis 1985, 44:155-158.
31. Madison DL, Allen E, Deodhar A. Henoch-Schönlein purpura: a possible complication of hepatitis C related liver cirrhosis. Ann Rheum Dis 2002, 61:281-282.
32. Ayoub EM, McBride J, Schmiederer M. Role of Bartonella henselae in the etiology of Henoch-Schönlein purpura. Pediatr Infect Dis J 2002, 21:28-31.
33. Al-Sheyyab M, Batieha A, El-Shanti H. Henoch-Schonlein purpura and streptococcal infection: a prospective case-control study. Ann Trop Paediatr 1999, 19:253-255.
34. Grech V, Vella C. Henoch-Schoenlein purpura with nephritis in two siblings following infectious mononucleosis. Ann Trop Paediatr 2002, 22:297-298.
35. Kalyoncu M, Odemis E, Yaris N. Association of Henoch-Schönlein purpura with varicella zoster. Indian Pediatr 2003, 40:274-275.
36. Islek I, Muslu A, Totan M. Henoch-Schönlein purpura and pulmonary tuberculosis. Pediatr Int 2002, 44:545-546.
37. Soylemezoglu O, Ozkaya O, Erbas D. Nitric oxide in Henoch-Schönlein purpura. Scand J Rheumatol 2002, 31:271-274.
38. Bosch X. Henoch-Schönlein purpura induced by losartan therapy. Arch Intern Med 1998, 158:191-192.
39. Borras-Blasco J, Enriquez R, Amoros F. Henoch-Schonlein purpura associated with clarithromycin. Int J Clin Pharmacol Ther 2003, 41:213-216.
40. Yang Y, Wang SJ, Chuang Y. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-[alpha] treatment in children with Henoch-Schönlein purpura. Clin Exp Immunol 2002, 130:352-357.
41. Huang MT, Lin SC, Lin YT. Increased transforming growth factor-beta (TGF [beta])-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin Exp Immunol 2000, 22:285-290.
42. Allen AC, Willis FR, Beattie TJ. Abnormal glycosylation of IgA1 in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998, 13:980-934.
43. Mestecky J, Hashim OH, Tomana M. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib Nephrol 1995, 111:66-72.
44. Jennette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitides. Arthritis Rheum 1994, 37:187-192.
45. Besbas N, Saatci U, Ruacan S. The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 1997, 26:456-460.
46. Muslu A, Islek I, Gok F. Endothelin levels in Henoch-Schonlein purpura. Pediatr Nephrol 2002, 11:920-925.
47. David S, Schiff JD, Poppas DP. Henoch-Schönlein purpura involving the glans penis. Urology 2003, 61:1035.
48. Saulbury FT. Hemorrhagic bullous lesions in Henoch-Schönlein purpura. Pediatr Dermatol 1998, 15:357-359.
49. Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD. Schönlein-Henoch purpura in adult patients. Arch Dermatol 1997, 133:438-442.
50. Kraft DM, Mckee D, Scott C. Henoch-Schönlein purpura: a review. Am Fam Phys 1998, 58:411-408.
51. Sano H, Izumida M, Shimizo H. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr 2002, 161:196-201.
52. Tizard EJ. Henoch-Schönlein purpura. Arch Dis Child 1999, 80:380-383.
53. Szer IS. Henoch-Schonlein purpura: when and how to treat. J Rheumatol 1996, 23:1661-1665.
54. Scharer K, Krmar R, Querfeld U. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999, 13:816-823.
55. Foster BJ, Bernard C, Drummond KN. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 2000, 136:370-375.
56. Lewis IC, Philpott MG. Neurologic complications in the Schonlein-Henoch syndrome. Arch Dis Child 1956, 31:369-371.
57. Nistala K, Hyer W, Halligan S. Jejunal haemorrhage in Henoch-Schonlein syndrome. Arch Dis Child 2003, 88:434.
58. Ma'luf RN, Zein WM, El Dairi MA. Bilateral subperiosteal orbital hematomas and Henoch-Schönlein purpura. Arch Ophthalmol 2002, 120:1398-1399.
59. Sokol DK, McIntyre JA, Short RA. Henoch-Schönlein purpura and stroke: antiphosphatidyl-ethanolamine antibody in CSF and serum. Neurology 2000, 55:1379-1381.
60. Mills JA, Michel BA, Bloch DA. The American College of Rheumatology 1990 Criteria for the Classification of Henoch-Schönlein purpura. Arthritis Rheum 1990, 33:1114-1121.
61. Davin J, Weening JJ. Henoch-Schonlein purpura nephritis: an update. Eur J Pediatr 2001, 160:689-695.
62. Grunwald MH, Avinoach I, Amichai B. Leukocytoclastic vasculitis - correlation between different histologic stages and direct immunofluorescence results. Int J Dermatol 1997, 36:349-352.
63. Egan CA, Taylor TB, Meyer LJ. IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schonlein purpura. Br J Dermatol 1999, 141:859-862.
64. Sais G, Vidaller A, Jucgla A. Pronostic factors in leukocytoclastic vasculitis. A clinicopathologic study of 160 patients. Arch Dermatol 1998, 134:309-315.
65. Murali NS, George R, John GT. Problems of classification of Henoch-Schonlein purpura: an Indian perspective. Clin Exp Dermatol 2002, 27:260-263.
66. Martino F, Agolini D, Tsalikova E. Nailfold capillaroscopy in Henoch-Schönlein purpura: a follow-up study of 31 cases. J Pediatr 2002, 141:145.
67. Steen CJ, Gascón P, Schwartz RA. eMedicine Medicine. 2008, http://author.emedicine.com/med/topic3495.htm, [journal series online], Available at: [accessed on 28 March 2009]
68. Shah D, Goraya JS, Poddar B. Acute infantile hemorrhagic edema and Henoch-Schönlein purpura overlap in a child. Pediatr Dermatol 2002, 19:92-93.
69. Swerdlin A, Berkowitz C, Craft N. Cutaneous signs of child abuse. J Am Acad Dermatol 2007, 57:371-392.
70. Matsukura H, Ohtsuki A, Fuchizawa T. Acute poststreptococcal glomerulonephritis mimicking Henoch-Schonlein purpura. Clin Nephrol 2003, 59:64-65.
71. Gardner FH, Diamond LK. Autoerythrocyte sensitization: a form of purpura producing painful bruising following autosensitization to red blood cells in certain women. Blood 1955, 10:675.
72. Hoffbrand BI. Dapsone in Henoch-Schonlein purpura: worth a trial. Postgrad Med J 1991, 67:961-962.
73. Prandota J, Pankow-Prandota L, Kotecki L. Impaired activation of the fibrinolytic system in children with Henoch-Schönlein purpura: beneficial effect of hydrocortisone plus σ-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 2001, 8:11-19.
74. Mollica F, Volti S, Garozzo R. Effectiveness of early prednisolone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Paediatr 1992, 151:140-144.
75. Reinehr T, Burk G, Andler W. Does steroid treatment of abdominal pain prevent renal involvement in Henoch-Schonlein purpura?. J Pediatr Gastroenterol Nutr 2000, 31:323-324.
76. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Schonlein purpura. Pediatr Nephrol 1993, 7:69-71.
77. Flynn JT, Smoyer WE, Bunchman TE. Treatment of Henoch-Schonlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001, 21:128-133.
78. Singh S, Devidayal T, Kumar L. Severe Henoch-Schonlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 2002, 22:133-137.
79. Kawasaki Y, Suzuki J, Nozawa R. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 2003, 111:785-789.
80. Motoshi H, Katsumi I, Konomoto T. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999, 33:427-433.
81. Saulsbury FT. Henoch-Schonlein purpura. Pediatr Dermatol 1984, 1:195-201.
82. Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in children with HSP. Pediatrics 1987, 79:1018-1021.
83. Glasier CM, Siegel MJ, McAlister WH. Henoch-Schonlein syndrome in children: gastrointestinal manifestations. Am J Roentgenol 1981, 136:1081-1085.
84. Leung SP. Use of intravenous hydrocortisone in Henoch-Schonlein purpura. J Pediatr Child Health 2001, 37:309-310.
85. Wang L, Huang FC, Ko SF. Successful treatment of mesenteric vasculitis caused by Henoch-Schonlein purpura with methylprednisolone pulse therapy. Clin Rheumatol 2003, 22:140-142.
86. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998, 53:1755-1759.
87. Huang D, Yang Y, Lin Y. Cyclosporin A therapy for steroid-dependent Henoch-Schönlein purpura. J Microbiol Immunol Infect 2003, 36:61-64.
88. Nakahata T, Tanaka H, Suzuki K. Successful treatment with leukocytapheresis in refractory Henoch-Schonlein purpura: case report. Clin Rheumatol 2003, 22:248-250.